Global Paclitaxel Drug-Eluting Balloon Supply, Demand and Key Producers, 2026-2032
The global Paclitaxel Drug-Eluting Balloon market size is expected to reach $ 3556 million by 2032, rising at a market growth of 12.3% CAGR during the forecast period (2026-2032).
Paclitaxel drug-eluting balloons (often referred to as paclitaxel drug-coated balloons, DCBs) are endovascular angioplasty balloons coated with paclitaxel plus an excipient/carrier system engineered for rapid, localized drug transfer. During inflation, the device delivers mechanical lumen gain while depositing paclitaxel into the vessel wall to inhibit smooth-muscle cell proliferation and migration, thereby reducing restenosis and repeat interventions. The clinical and commercial proposition centers on ?leave nothing behind?: achieving durable antiproliferative effect without a permanent implant, which helps avoid the long-term burden of metallic scaffolds such as chronic inflammation, imaging artifacts, and constraints on future revascularization. Paclitaxel DEBs are particularly relevant in peripheral arterial disease (e.g., femoropopliteal lesions), dialysis access maintenance, and selected coronary scenarios including in-stent restenosis and small-vessel disease. Differentiation increasingly hinges on drug crystallinity, coating integrity, and transfer efficiency enabled by manufacturing know-how.In 2025, global Paclitaxel drug-eluting balloons production reached approximately 1528 k units and price is 995 USD/Unit.The average gross profit margin of this product is 73%.
Growth is shifting from ?device substitution? toward broader adoption of a standardized vascular-repair strategy. The regulatory and evidence boundary has become clearer: the U.S. FDA updated its communication noting that the totality of available data does not support an excess mortality risk for paclitaxel-coated devices used to treat PAD, enabling more actionable hospital governance and pathway deployment. In parallel, leading multinationals continue to highlight the momentum and acceptance of drug-coated balloon portfolios in annual reporting, underscoring rising strategic weight as peripheral intervention evolves ?from implants to repair.?
The main hurdle is no longer ?does it work,? but ?can it scale compliantly and sustainably.? Although paclitaxel safety concerns have substantially de-risked, long-term follow-up and real-world evidence will remain under scrutiny?making lifecycle risk management and manufacturing consistency non-negotiable. Meanwhile, procurement and cost-containment mechanisms intensify competition beyond performance into supply assurance and quality systems; in China, centralized procurement dynamics accelerate a more rules-based, scale-driven market phase, pushing manufacturers to harden cost efficiency, delivery reliability, and compliance capabilities.
Demand is moving toward ?adjunct devices + repeatable technique.? Clinicians increasingly integrate lesion preparation, optimized drug transfer, and long-term outcomes into a single procedural narrative, strengthening combination use of paclitaxel DEBs with atherectomy/plaque-modification tools, specialty scoring balloons, and intravascular imaging (IVUS/OCT). At the same time, high-recurrence, reintervention-sensitive settings (e.g., femoropopliteal disease and dialysis access) favor an implant-avoidance philosophy, broadening hospital-level adoption of the ?leave nothing behind? value proposition.
Upstream differentiation is ultimately a coupled ?materials + process chain? capability. Key inputs include balloon and catheter polymers (films, multi-durometer shafts, liners, and reinforcement braids/coils), paclitaxel API with crystallinity control, excipient/carrier systems and coating solvents, lubricious/hydrophilic surface coatings, plus sterile barrier packaging and sterilization services. Compared with standard PTA balloons, paclitaxel DEBs are far more sensitive to coating integrity, particulate control, batch-to-batch dose consistency, and stability?requiring medical-grade traceability, rigorous change control, clean manufacturing, and deeper co-development/validation lock-in with upstream partners.
This report studies the global Paclitaxel Drug-Eluting Balloon production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Paclitaxel Drug-Eluting Balloon and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Paclitaxel Drug-Eluting Balloon that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Paclitaxel Drug-Eluting Balloon total production and demand, 2021-2032, (K Units)
Global Paclitaxel Drug-Eluting Balloon total production value, 2021-2032, (USD Million)
Global Paclitaxel Drug-Eluting Balloon production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)
Global Paclitaxel Drug-Eluting Balloon consumption by region & country, CAGR, 2021-2032 & (K Units)
U.S. VS China: Paclitaxel Drug-Eluting Balloon domestic production, consumption, key domestic manufacturers and share
Global Paclitaxel Drug-Eluting Balloon production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)
Global Paclitaxel Drug-Eluting Balloon production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
Global Paclitaxel Drug-Eluting Balloon production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
This report profiles key players in the global Paclitaxel Drug-Eluting Balloon market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include B. Braun, Medtronic, Boston Scientific, BD, Yinyi Biotechnology, Acotec, Philips, Lepu Medical, Eurocor, MicroPort Medical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Paclitaxel Drug-Eluting Balloon market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Paclitaxel Drug-Eluting Balloon Market, By Region:
1. How big is the global Paclitaxel Drug-Eluting Balloon market?
2. What is the demand of the global Paclitaxel Drug-Eluting Balloon market?
3. What is the year over year growth of the global Paclitaxel Drug-Eluting Balloon market?
4. What is the production and production value of the global Paclitaxel Drug-Eluting Balloon market?
5. Who are the key producers in the global Paclitaxel Drug-Eluting Balloon market?
6. What are the growth factors driving the market demand?
Paclitaxel drug-eluting balloons (often referred to as paclitaxel drug-coated balloons, DCBs) are endovascular angioplasty balloons coated with paclitaxel plus an excipient/carrier system engineered for rapid, localized drug transfer. During inflation, the device delivers mechanical lumen gain while depositing paclitaxel into the vessel wall to inhibit smooth-muscle cell proliferation and migration, thereby reducing restenosis and repeat interventions. The clinical and commercial proposition centers on ?leave nothing behind?: achieving durable antiproliferative effect without a permanent implant, which helps avoid the long-term burden of metallic scaffolds such as chronic inflammation, imaging artifacts, and constraints on future revascularization. Paclitaxel DEBs are particularly relevant in peripheral arterial disease (e.g., femoropopliteal lesions), dialysis access maintenance, and selected coronary scenarios including in-stent restenosis and small-vessel disease. Differentiation increasingly hinges on drug crystallinity, coating integrity, and transfer efficiency enabled by manufacturing know-how.In 2025, global Paclitaxel drug-eluting balloons production reached approximately 1528 k units and price is 995 USD/Unit.The average gross profit margin of this product is 73%.
Growth is shifting from ?device substitution? toward broader adoption of a standardized vascular-repair strategy. The regulatory and evidence boundary has become clearer: the U.S. FDA updated its communication noting that the totality of available data does not support an excess mortality risk for paclitaxel-coated devices used to treat PAD, enabling more actionable hospital governance and pathway deployment. In parallel, leading multinationals continue to highlight the momentum and acceptance of drug-coated balloon portfolios in annual reporting, underscoring rising strategic weight as peripheral intervention evolves ?from implants to repair.?
The main hurdle is no longer ?does it work,? but ?can it scale compliantly and sustainably.? Although paclitaxel safety concerns have substantially de-risked, long-term follow-up and real-world evidence will remain under scrutiny?making lifecycle risk management and manufacturing consistency non-negotiable. Meanwhile, procurement and cost-containment mechanisms intensify competition beyond performance into supply assurance and quality systems; in China, centralized procurement dynamics accelerate a more rules-based, scale-driven market phase, pushing manufacturers to harden cost efficiency, delivery reliability, and compliance capabilities.
Demand is moving toward ?adjunct devices + repeatable technique.? Clinicians increasingly integrate lesion preparation, optimized drug transfer, and long-term outcomes into a single procedural narrative, strengthening combination use of paclitaxel DEBs with atherectomy/plaque-modification tools, specialty scoring balloons, and intravascular imaging (IVUS/OCT). At the same time, high-recurrence, reintervention-sensitive settings (e.g., femoropopliteal disease and dialysis access) favor an implant-avoidance philosophy, broadening hospital-level adoption of the ?leave nothing behind? value proposition.
Upstream differentiation is ultimately a coupled ?materials + process chain? capability. Key inputs include balloon and catheter polymers (films, multi-durometer shafts, liners, and reinforcement braids/coils), paclitaxel API with crystallinity control, excipient/carrier systems and coating solvents, lubricious/hydrophilic surface coatings, plus sterile barrier packaging and sterilization services. Compared with standard PTA balloons, paclitaxel DEBs are far more sensitive to coating integrity, particulate control, batch-to-batch dose consistency, and stability?requiring medical-grade traceability, rigorous change control, clean manufacturing, and deeper co-development/validation lock-in with upstream partners.
This report studies the global Paclitaxel Drug-Eluting Balloon production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Paclitaxel Drug-Eluting Balloon and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Paclitaxel Drug-Eluting Balloon that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Paclitaxel Drug-Eluting Balloon total production and demand, 2021-2032, (K Units)
Global Paclitaxel Drug-Eluting Balloon total production value, 2021-2032, (USD Million)
Global Paclitaxel Drug-Eluting Balloon production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)
Global Paclitaxel Drug-Eluting Balloon consumption by region & country, CAGR, 2021-2032 & (K Units)
U.S. VS China: Paclitaxel Drug-Eluting Balloon domestic production, consumption, key domestic manufacturers and share
Global Paclitaxel Drug-Eluting Balloon production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)
Global Paclitaxel Drug-Eluting Balloon production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
Global Paclitaxel Drug-Eluting Balloon production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
This report profiles key players in the global Paclitaxel Drug-Eluting Balloon market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include B. Braun, Medtronic, Boston Scientific, BD, Yinyi Biotechnology, Acotec, Philips, Lepu Medical, Eurocor, MicroPort Medical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Paclitaxel Drug-Eluting Balloon market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Paclitaxel Drug-Eluting Balloon Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Peripheral DEB
- Coronary DEB
- In-Stent Restenosi
- De Novo
- Small Vessel
- Semi-/Compliant
- Non-compliant
- Other
- Cardiac Catheterization Lab
- Hospital
- Other
- B. Braun
- Medtronic
- Boston Scientific
- BD
- Yinyi Biotechnology
- Acotec
- Philips
- Lepu Medical
- Eurocor
- MicroPort Medical
- Teleflex
1. How big is the global Paclitaxel Drug-Eluting Balloon market?
2. What is the demand of the global Paclitaxel Drug-Eluting Balloon market?
3. What is the year over year growth of the global Paclitaxel Drug-Eluting Balloon market?
4. What is the production and production value of the global Paclitaxel Drug-Eluting Balloon market?
5. Who are the key producers in the global Paclitaxel Drug-Eluting Balloon market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Paclitaxel Drug-Eluting Balloon Introduction
1.2 World Paclitaxel Drug-Eluting Balloon Supply & Forecast
1.2.1 World Paclitaxel Drug-Eluting Balloon Production Value (2021 & 2025 & 2032)
1.2.2 World Paclitaxel Drug-Eluting Balloon Production (2021-2032)
1.2.3 World Paclitaxel Drug-Eluting Balloon Pricing Trends (2021-2032)
1.3 World Paclitaxel Drug-Eluting Balloon Production by Region (Based on Production Site)
1.3.1 World Paclitaxel Drug-Eluting Balloon Production Value by Region (2021-2032)
1.3.2 World Paclitaxel Drug-Eluting Balloon Production by Region (2021-2032)
1.3.3 World Paclitaxel Drug-Eluting Balloon Average Price by Region (2021-2032)
1.3.4 North America Paclitaxel Drug-Eluting Balloon Production (2021-2032)
1.3.5 Europe Paclitaxel Drug-Eluting Balloon Production (2021-2032)
1.3.6 China Paclitaxel Drug-Eluting Balloon Production (2021-2032)
1.3.7 Japan Paclitaxel Drug-Eluting Balloon Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Paclitaxel Drug-Eluting Balloon Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Paclitaxel Drug-Eluting Balloon Major Market Trends
2 DEMAND SUMMARY
2.1 World Paclitaxel Drug-Eluting Balloon Demand (2021-2032)
2.2 World Paclitaxel Drug-Eluting Balloon Consumption by Region
2.2.1 World Paclitaxel Drug-Eluting Balloon Consumption by Region (2021-2026)
2.2.2 World Paclitaxel Drug-Eluting Balloon Consumption Forecast by Region (2027-2032)
2.3 United States Paclitaxel Drug-Eluting Balloon Consumption (2021-2032)
2.4 China Paclitaxel Drug-Eluting Balloon Consumption (2021-2032)
2.5 Europe Paclitaxel Drug-Eluting Balloon Consumption (2021-2032)
2.6 Japan Paclitaxel Drug-Eluting Balloon Consumption (2021-2032)
2.7 South Korea Paclitaxel Drug-Eluting Balloon Consumption (2021-2032)
2.8 ASEAN Paclitaxel Drug-Eluting Balloon Consumption (2021-2032)
2.9 India Paclitaxel Drug-Eluting Balloon Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Paclitaxel Drug-Eluting Balloon Production Value by Manufacturer (2021-2026)
3.2 World Paclitaxel Drug-Eluting Balloon Production by Manufacturer (2021-2026)
3.3 World Paclitaxel Drug-Eluting Balloon Average Price by Manufacturer (2021-2026)
3.4 Paclitaxel Drug-Eluting Balloon Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Paclitaxel Drug-Eluting Balloon Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Paclitaxel Drug-Eluting Balloon in 2025
3.5.3 Global Concentration Ratios (CR8) for Paclitaxel Drug-Eluting Balloon in 2025
3.6 Paclitaxel Drug-Eluting Balloon Market: Overall Company Footprint Analysis
3.6.1 Paclitaxel Drug-Eluting Balloon Market: Region Footprint
3.6.2 Paclitaxel Drug-Eluting Balloon Market: Company Product Type Footprint
3.6.3 Paclitaxel Drug-Eluting Balloon Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Paclitaxel Drug-Eluting Balloon Production Value Comparison
4.1.1 United States VS China: Paclitaxel Drug-Eluting Balloon Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Paclitaxel Drug-Eluting Balloon Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Paclitaxel Drug-Eluting Balloon Production Comparison
4.2.1 United States VS China: Paclitaxel Drug-Eluting Balloon Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Paclitaxel Drug-Eluting Balloon Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Paclitaxel Drug-Eluting Balloon Consumption Comparison
4.3.1 United States VS China: Paclitaxel Drug-Eluting Balloon Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Paclitaxel Drug-Eluting Balloon Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Paclitaxel Drug-Eluting Balloon Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Paclitaxel Drug-Eluting Balloon Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Paclitaxel Drug-Eluting Balloon Production Value (2021-2026)
4.4.3 United States Based Manufacturers Paclitaxel Drug-Eluting Balloon Production (2021-2026)
4.5 China Based Paclitaxel Drug-Eluting Balloon Manufacturers and Market Share
4.5.1 China Based Paclitaxel Drug-Eluting Balloon Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Paclitaxel Drug-Eluting Balloon Production Value (2021-2026)
4.5.3 China Based Manufacturers Paclitaxel Drug-Eluting Balloon Production (2021-2026)
4.6 Rest of World Based Paclitaxel Drug-Eluting Balloon Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Paclitaxel Drug-Eluting Balloon Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Paclitaxel Drug-Eluting Balloon Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Paclitaxel Drug-Eluting Balloon Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Paclitaxel Drug-Eluting Balloon Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Peripheral DEB
5.2.2 Coronary DEB
5.3 Market Segment by Type
5.3.1 World Paclitaxel Drug-Eluting Balloon Production by Type (2021-2032)
5.3.2 World Paclitaxel Drug-Eluting Balloon Production Value by Type (2021-2032)
5.3.3 World Paclitaxel Drug-Eluting Balloon Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY USE SCENARIO
6.1 World Paclitaxel Drug-Eluting Balloon Market Size Overview by Use Scenario: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Use Scenario
6.2.1 In-Stent Restenosi
6.2.2 De Novo
6.2.3 Small Vessel
6.3 Market Segment by Use Scenario
6.3.1 World Paclitaxel Drug-Eluting Balloon Production by Use Scenario (2021-2032)
6.3.2 World Paclitaxel Drug-Eluting Balloon Production Value by Use Scenario (2021-2032)
6.3.3 World Paclitaxel Drug-Eluting Balloon Average Price by Use Scenario (2021-2032)
7 MARKET ANALYSIS BY BALLOON PLATFORM MECHANICS
7.1 World Paclitaxel Drug-Eluting Balloon Market Size Overview by Balloon Platform Mechanics: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Balloon Platform Mechanics
7.2.1 Semi-/Compliant
7.2.2 Non-compliant
7.2.3 Other
7.3 Market Segment by Balloon Platform Mechanics
7.3.1 World Paclitaxel Drug-Eluting Balloon Production by Balloon Platform Mechanics (2021-2032)
7.3.2 World Paclitaxel Drug-Eluting Balloon Production Value by Balloon Platform Mechanics (2021-2032)
7.3.3 World Paclitaxel Drug-Eluting Balloon Average Price by Balloon Platform Mechanics (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Paclitaxel Drug-Eluting Balloon Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Cardiac Catheterization Lab
8.2.2 Hospital
8.2.3 Other
8.3 Market Segment by Application
8.3.1 World Paclitaxel Drug-Eluting Balloon Production by Application (2021-2032)
8.3.2 World Paclitaxel Drug-Eluting Balloon Production Value by Application (2021-2032)
8.3.3 World Paclitaxel Drug-Eluting Balloon Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 B. Braun
9.1.1 B. Braun Details
9.1.2 B. Braun Major Business
9.1.3 B. Braun Paclitaxel Drug-Eluting Balloon Product and Services
9.1.4 B. Braun Paclitaxel Drug-Eluting Balloon Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 B. Braun Recent Developments/Updates
9.1.6 B. Braun Competitive Strengths & Weaknesses
9.2 Medtronic
9.2.1 Medtronic Details
9.2.2 Medtronic Major Business
9.2.3 Medtronic Paclitaxel Drug-Eluting Balloon Product and Services
9.2.4 Medtronic Paclitaxel Drug-Eluting Balloon Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Medtronic Recent Developments/Updates
9.2.6 Medtronic Competitive Strengths & Weaknesses
9.3 Boston Scientific
9.3.1 Boston Scientific Details
9.3.2 Boston Scientific Major Business
9.3.3 Boston Scientific Paclitaxel Drug-Eluting Balloon Product and Services
9.3.4 Boston Scientific Paclitaxel Drug-Eluting Balloon Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Boston Scientific Recent Developments/Updates
9.3.6 Boston Scientific Competitive Strengths & Weaknesses
9.4 BD
9.4.1 BD Details
9.4.2 BD Major Business
9.4.3 BD Paclitaxel Drug-Eluting Balloon Product and Services
9.4.4 BD Paclitaxel Drug-Eluting Balloon Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 BD Recent Developments/Updates
9.4.6 BD Competitive Strengths & Weaknesses
9.5 Yinyi Biotechnology
9.5.1 Yinyi Biotechnology Details
9.5.2 Yinyi Biotechnology Major Business
9.5.3 Yinyi Biotechnology Paclitaxel Drug-Eluting Balloon Product and Services
9.5.4 Yinyi Biotechnology Paclitaxel Drug-Eluting Balloon Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Yinyi Biotechnology Recent Developments/Updates
9.5.6 Yinyi Biotechnology Competitive Strengths & Weaknesses
9.6 Acotec
9.6.1 Acotec Details
9.6.2 Acotec Major Business
9.6.3 Acotec Paclitaxel Drug-Eluting Balloon Product and Services
9.6.4 Acotec Paclitaxel Drug-Eluting Balloon Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 Acotec Recent Developments/Updates
9.6.6 Acotec Competitive Strengths & Weaknesses
9.7 Philips
9.7.1 Philips Details
9.7.2 Philips Major Business
9.7.3 Philips Paclitaxel Drug-Eluting Balloon Product and Services
9.7.4 Philips Paclitaxel Drug-Eluting Balloon Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Philips Recent Developments/Updates
9.7.6 Philips Competitive Strengths & Weaknesses
9.8 Lepu Medical
9.8.1 Lepu Medical Details
9.8.2 Lepu Medical Major Business
9.8.3 Lepu Medical Paclitaxel Drug-Eluting Balloon Product and Services
9.8.4 Lepu Medical Paclitaxel Drug-Eluting Balloon Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 Lepu Medical Recent Developments/Updates
9.8.6 Lepu Medical Competitive Strengths & Weaknesses
9.9 Eurocor
9.9.1 Eurocor Details
9.9.2 Eurocor Major Business
9.9.3 Eurocor Paclitaxel Drug-Eluting Balloon Product and Services
9.9.4 Eurocor Paclitaxel Drug-Eluting Balloon Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Eurocor Recent Developments/Updates
9.9.6 Eurocor Competitive Strengths & Weaknesses
9.10 MicroPort Medical
9.10.1 MicroPort Medical Details
9.10.2 MicroPort Medical Major Business
9.10.3 MicroPort Medical Paclitaxel Drug-Eluting Balloon Product and Services
9.10.4 MicroPort Medical Paclitaxel Drug-Eluting Balloon Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 MicroPort Medical Recent Developments/Updates
9.10.6 MicroPort Medical Competitive Strengths & Weaknesses
9.11 Teleflex
9.11.1 Teleflex Details
9.11.2 Teleflex Major Business
9.11.3 Teleflex Paclitaxel Drug-Eluting Balloon Product and Services
9.11.4 Teleflex Paclitaxel Drug-Eluting Balloon Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.11.5 Teleflex Recent Developments/Updates
9.11.6 Teleflex Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Paclitaxel Drug-Eluting Balloon Industry Chain
10.2 Paclitaxel Drug-Eluting Balloon Upstream Analysis
10.2.1 Paclitaxel Drug-Eluting Balloon Core Raw Materials
10.2.2 Main Manufacturers of Paclitaxel Drug-Eluting Balloon Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Paclitaxel Drug-Eluting Balloon Production Mode
10.6 Paclitaxel Drug-Eluting Balloon Procurement Model
10.7 Paclitaxel Drug-Eluting Balloon Industry Sales Model and Sales Channels
10.7.1 Paclitaxel Drug-Eluting Balloon Sales Model
10.7.2 Paclitaxel Drug-Eluting Balloon Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Paclitaxel Drug-Eluting Balloon Introduction
1.2 World Paclitaxel Drug-Eluting Balloon Supply & Forecast
1.2.1 World Paclitaxel Drug-Eluting Balloon Production Value (2021 & 2025 & 2032)
1.2.2 World Paclitaxel Drug-Eluting Balloon Production (2021-2032)
1.2.3 World Paclitaxel Drug-Eluting Balloon Pricing Trends (2021-2032)
1.3 World Paclitaxel Drug-Eluting Balloon Production by Region (Based on Production Site)
1.3.1 World Paclitaxel Drug-Eluting Balloon Production Value by Region (2021-2032)
1.3.2 World Paclitaxel Drug-Eluting Balloon Production by Region (2021-2032)
1.3.3 World Paclitaxel Drug-Eluting Balloon Average Price by Region (2021-2032)
1.3.4 North America Paclitaxel Drug-Eluting Balloon Production (2021-2032)
1.3.5 Europe Paclitaxel Drug-Eluting Balloon Production (2021-2032)
1.3.6 China Paclitaxel Drug-Eluting Balloon Production (2021-2032)
1.3.7 Japan Paclitaxel Drug-Eluting Balloon Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Paclitaxel Drug-Eluting Balloon Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Paclitaxel Drug-Eluting Balloon Major Market Trends
2 DEMAND SUMMARY
2.1 World Paclitaxel Drug-Eluting Balloon Demand (2021-2032)
2.2 World Paclitaxel Drug-Eluting Balloon Consumption by Region
2.2.1 World Paclitaxel Drug-Eluting Balloon Consumption by Region (2021-2026)
2.2.2 World Paclitaxel Drug-Eluting Balloon Consumption Forecast by Region (2027-2032)
2.3 United States Paclitaxel Drug-Eluting Balloon Consumption (2021-2032)
2.4 China Paclitaxel Drug-Eluting Balloon Consumption (2021-2032)
2.5 Europe Paclitaxel Drug-Eluting Balloon Consumption (2021-2032)
2.6 Japan Paclitaxel Drug-Eluting Balloon Consumption (2021-2032)
2.7 South Korea Paclitaxel Drug-Eluting Balloon Consumption (2021-2032)
2.8 ASEAN Paclitaxel Drug-Eluting Balloon Consumption (2021-2032)
2.9 India Paclitaxel Drug-Eluting Balloon Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Paclitaxel Drug-Eluting Balloon Production Value by Manufacturer (2021-2026)
3.2 World Paclitaxel Drug-Eluting Balloon Production by Manufacturer (2021-2026)
3.3 World Paclitaxel Drug-Eluting Balloon Average Price by Manufacturer (2021-2026)
3.4 Paclitaxel Drug-Eluting Balloon Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Paclitaxel Drug-Eluting Balloon Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Paclitaxel Drug-Eluting Balloon in 2025
3.5.3 Global Concentration Ratios (CR8) for Paclitaxel Drug-Eluting Balloon in 2025
3.6 Paclitaxel Drug-Eluting Balloon Market: Overall Company Footprint Analysis
3.6.1 Paclitaxel Drug-Eluting Balloon Market: Region Footprint
3.6.2 Paclitaxel Drug-Eluting Balloon Market: Company Product Type Footprint
3.6.3 Paclitaxel Drug-Eluting Balloon Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Paclitaxel Drug-Eluting Balloon Production Value Comparison
4.1.1 United States VS China: Paclitaxel Drug-Eluting Balloon Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Paclitaxel Drug-Eluting Balloon Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Paclitaxel Drug-Eluting Balloon Production Comparison
4.2.1 United States VS China: Paclitaxel Drug-Eluting Balloon Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Paclitaxel Drug-Eluting Balloon Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Paclitaxel Drug-Eluting Balloon Consumption Comparison
4.3.1 United States VS China: Paclitaxel Drug-Eluting Balloon Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Paclitaxel Drug-Eluting Balloon Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Paclitaxel Drug-Eluting Balloon Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Paclitaxel Drug-Eluting Balloon Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Paclitaxel Drug-Eluting Balloon Production Value (2021-2026)
4.4.3 United States Based Manufacturers Paclitaxel Drug-Eluting Balloon Production (2021-2026)
4.5 China Based Paclitaxel Drug-Eluting Balloon Manufacturers and Market Share
4.5.1 China Based Paclitaxel Drug-Eluting Balloon Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Paclitaxel Drug-Eluting Balloon Production Value (2021-2026)
4.5.3 China Based Manufacturers Paclitaxel Drug-Eluting Balloon Production (2021-2026)
4.6 Rest of World Based Paclitaxel Drug-Eluting Balloon Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Paclitaxel Drug-Eluting Balloon Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Paclitaxel Drug-Eluting Balloon Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Paclitaxel Drug-Eluting Balloon Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Paclitaxel Drug-Eluting Balloon Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Peripheral DEB
5.2.2 Coronary DEB
5.3 Market Segment by Type
5.3.1 World Paclitaxel Drug-Eluting Balloon Production by Type (2021-2032)
5.3.2 World Paclitaxel Drug-Eluting Balloon Production Value by Type (2021-2032)
5.3.3 World Paclitaxel Drug-Eluting Balloon Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY USE SCENARIO
6.1 World Paclitaxel Drug-Eluting Balloon Market Size Overview by Use Scenario: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Use Scenario
6.2.1 In-Stent Restenosi
6.2.2 De Novo
6.2.3 Small Vessel
6.3 Market Segment by Use Scenario
6.3.1 World Paclitaxel Drug-Eluting Balloon Production by Use Scenario (2021-2032)
6.3.2 World Paclitaxel Drug-Eluting Balloon Production Value by Use Scenario (2021-2032)
6.3.3 World Paclitaxel Drug-Eluting Balloon Average Price by Use Scenario (2021-2032)
7 MARKET ANALYSIS BY BALLOON PLATFORM MECHANICS
7.1 World Paclitaxel Drug-Eluting Balloon Market Size Overview by Balloon Platform Mechanics: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Balloon Platform Mechanics
7.2.1 Semi-/Compliant
7.2.2 Non-compliant
7.2.3 Other
7.3 Market Segment by Balloon Platform Mechanics
7.3.1 World Paclitaxel Drug-Eluting Balloon Production by Balloon Platform Mechanics (2021-2032)
7.3.2 World Paclitaxel Drug-Eluting Balloon Production Value by Balloon Platform Mechanics (2021-2032)
7.3.3 World Paclitaxel Drug-Eluting Balloon Average Price by Balloon Platform Mechanics (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Paclitaxel Drug-Eluting Balloon Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Cardiac Catheterization Lab
8.2.2 Hospital
8.2.3 Other
8.3 Market Segment by Application
8.3.1 World Paclitaxel Drug-Eluting Balloon Production by Application (2021-2032)
8.3.2 World Paclitaxel Drug-Eluting Balloon Production Value by Application (2021-2032)
8.3.3 World Paclitaxel Drug-Eluting Balloon Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 B. Braun
9.1.1 B. Braun Details
9.1.2 B. Braun Major Business
9.1.3 B. Braun Paclitaxel Drug-Eluting Balloon Product and Services
9.1.4 B. Braun Paclitaxel Drug-Eluting Balloon Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 B. Braun Recent Developments/Updates
9.1.6 B. Braun Competitive Strengths & Weaknesses
9.2 Medtronic
9.2.1 Medtronic Details
9.2.2 Medtronic Major Business
9.2.3 Medtronic Paclitaxel Drug-Eluting Balloon Product and Services
9.2.4 Medtronic Paclitaxel Drug-Eluting Balloon Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Medtronic Recent Developments/Updates
9.2.6 Medtronic Competitive Strengths & Weaknesses
9.3 Boston Scientific
9.3.1 Boston Scientific Details
9.3.2 Boston Scientific Major Business
9.3.3 Boston Scientific Paclitaxel Drug-Eluting Balloon Product and Services
9.3.4 Boston Scientific Paclitaxel Drug-Eluting Balloon Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Boston Scientific Recent Developments/Updates
9.3.6 Boston Scientific Competitive Strengths & Weaknesses
9.4 BD
9.4.1 BD Details
9.4.2 BD Major Business
9.4.3 BD Paclitaxel Drug-Eluting Balloon Product and Services
9.4.4 BD Paclitaxel Drug-Eluting Balloon Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 BD Recent Developments/Updates
9.4.6 BD Competitive Strengths & Weaknesses
9.5 Yinyi Biotechnology
9.5.1 Yinyi Biotechnology Details
9.5.2 Yinyi Biotechnology Major Business
9.5.3 Yinyi Biotechnology Paclitaxel Drug-Eluting Balloon Product and Services
9.5.4 Yinyi Biotechnology Paclitaxel Drug-Eluting Balloon Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Yinyi Biotechnology Recent Developments/Updates
9.5.6 Yinyi Biotechnology Competitive Strengths & Weaknesses
9.6 Acotec
9.6.1 Acotec Details
9.6.2 Acotec Major Business
9.6.3 Acotec Paclitaxel Drug-Eluting Balloon Product and Services
9.6.4 Acotec Paclitaxel Drug-Eluting Balloon Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 Acotec Recent Developments/Updates
9.6.6 Acotec Competitive Strengths & Weaknesses
9.7 Philips
9.7.1 Philips Details
9.7.2 Philips Major Business
9.7.3 Philips Paclitaxel Drug-Eluting Balloon Product and Services
9.7.4 Philips Paclitaxel Drug-Eluting Balloon Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Philips Recent Developments/Updates
9.7.6 Philips Competitive Strengths & Weaknesses
9.8 Lepu Medical
9.8.1 Lepu Medical Details
9.8.2 Lepu Medical Major Business
9.8.3 Lepu Medical Paclitaxel Drug-Eluting Balloon Product and Services
9.8.4 Lepu Medical Paclitaxel Drug-Eluting Balloon Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 Lepu Medical Recent Developments/Updates
9.8.6 Lepu Medical Competitive Strengths & Weaknesses
9.9 Eurocor
9.9.1 Eurocor Details
9.9.2 Eurocor Major Business
9.9.3 Eurocor Paclitaxel Drug-Eluting Balloon Product and Services
9.9.4 Eurocor Paclitaxel Drug-Eluting Balloon Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Eurocor Recent Developments/Updates
9.9.6 Eurocor Competitive Strengths & Weaknesses
9.10 MicroPort Medical
9.10.1 MicroPort Medical Details
9.10.2 MicroPort Medical Major Business
9.10.3 MicroPort Medical Paclitaxel Drug-Eluting Balloon Product and Services
9.10.4 MicroPort Medical Paclitaxel Drug-Eluting Balloon Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 MicroPort Medical Recent Developments/Updates
9.10.6 MicroPort Medical Competitive Strengths & Weaknesses
9.11 Teleflex
9.11.1 Teleflex Details
9.11.2 Teleflex Major Business
9.11.3 Teleflex Paclitaxel Drug-Eluting Balloon Product and Services
9.11.4 Teleflex Paclitaxel Drug-Eluting Balloon Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.11.5 Teleflex Recent Developments/Updates
9.11.6 Teleflex Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Paclitaxel Drug-Eluting Balloon Industry Chain
10.2 Paclitaxel Drug-Eluting Balloon Upstream Analysis
10.2.1 Paclitaxel Drug-Eluting Balloon Core Raw Materials
10.2.2 Main Manufacturers of Paclitaxel Drug-Eluting Balloon Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Paclitaxel Drug-Eluting Balloon Production Mode
10.6 Paclitaxel Drug-Eluting Balloon Procurement Model
10.7 Paclitaxel Drug-Eluting Balloon Industry Sales Model and Sales Channels
10.7.1 Paclitaxel Drug-Eluting Balloon Sales Model
10.7.2 Paclitaxel Drug-Eluting Balloon Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Paclitaxel Drug-Eluting Balloon Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Paclitaxel Drug-Eluting Balloon Production Value by Region (2021-2026) & (USD Million)
Table 3. World Paclitaxel Drug-Eluting Balloon Production Value by Region (2027-2032) & (USD Million)
Table 4. World Paclitaxel Drug-Eluting Balloon Production Value Market Share by Region (2021-2026)
Table 5. World Paclitaxel Drug-Eluting Balloon Production Value Market Share by Region (2027-2032)
Table 6. World Paclitaxel Drug-Eluting Balloon Production by Region (2021-2026) & (K Units)
Table 7. World Paclitaxel Drug-Eluting Balloon Production by Region (2027-2032) & (K Units)
Table 8. World Paclitaxel Drug-Eluting Balloon Production Market Share by Region (2021-2026)
Table 9. World Paclitaxel Drug-Eluting Balloon Production Market Share by Region (2027-2032)
Table 10. World Paclitaxel Drug-Eluting Balloon Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Paclitaxel Drug-Eluting Balloon Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Paclitaxel Drug-Eluting Balloon Major Market Trends
Table 13. World Paclitaxel Drug-Eluting Balloon Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Units)
Table 14. World Paclitaxel Drug-Eluting Balloon Consumption by Region (2021-2026) & (K Units)
Table 15. World Paclitaxel Drug-Eluting Balloon Consumption Forecast by Region (2027-2032) & (K Units)
Table 16. World Paclitaxel Drug-Eluting Balloon Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Paclitaxel Drug-Eluting Balloon Producers in 2025
Table 18. World Paclitaxel Drug-Eluting Balloon Production by Manufacturer (2021-2026) & (K Units)
Table 19. Production Market Share of Key Paclitaxel Drug-Eluting Balloon Producers in 2025
Table 20. World Paclitaxel Drug-Eluting Balloon Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Paclitaxel Drug-Eluting Balloon Company Evaluation Quadrant
Table 22. World Paclitaxel Drug-Eluting Balloon Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Paclitaxel Drug-Eluting Balloon Production Site of Key Manufacturer
Table 24. Paclitaxel Drug-Eluting Balloon Market: Company Product Type Footprint
Table 25. Paclitaxel Drug-Eluting Balloon Market: Company Product Application Footprint
Table 26. Paclitaxel Drug-Eluting Balloon Competitive Factors
Table 27. Paclitaxel Drug-Eluting Balloon New Entrant and Capacity Expansion Plans
Table 28. Paclitaxel Drug-Eluting Balloon Mergers & Acquisitions Activity
Table 29. United States VS China Paclitaxel Drug-Eluting Balloon Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Paclitaxel Drug-Eluting Balloon Production Comparison, (2021 & 2025 & 2032) & (K Units)
Table 31. United States VS China Paclitaxel Drug-Eluting Balloon Consumption Comparison, (2021 & 2025 & 2032) & (K Units)
Table 32. United States Based Paclitaxel Drug-Eluting Balloon Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Paclitaxel Drug-Eluting Balloon Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Paclitaxel Drug-Eluting Balloon Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Paclitaxel Drug-Eluting Balloon Production (2021-2026) & (K Units)
Table 36. United States Based Manufacturers Paclitaxel Drug-Eluting Balloon Production Market Share (2021-2026)
Table 37. China Based Paclitaxel Drug-Eluting Balloon Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Paclitaxel Drug-Eluting Balloon Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Paclitaxel Drug-Eluting Balloon Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Paclitaxel Drug-Eluting Balloon Production, (2021-2026) & (K Units)
Table 41. China Based Manufacturers Paclitaxel Drug-Eluting Balloon Production Market Share (2021-2026)
Table 42. Rest of World Based Paclitaxel Drug-Eluting Balloon Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Paclitaxel Drug-Eluting Balloon Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Paclitaxel Drug-Eluting Balloon Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Paclitaxel Drug-Eluting Balloon Production, (2021-2026) & (K Units)
Table 46. Rest of World Based Manufacturers Paclitaxel Drug-Eluting Balloon Production Market Share (2021-2026)
Table 47. World Paclitaxel Drug-Eluting Balloon Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Paclitaxel Drug-Eluting Balloon Production by Type (2021-2026) & (K Units)
Table 49. World Paclitaxel Drug-Eluting Balloon Production by Type (2027-2032) & (K Units)
Table 50. World Paclitaxel Drug-Eluting Balloon Production Value by Type (2021-2026) & (USD Million)
Table 51. World Paclitaxel Drug-Eluting Balloon Production Value by Type (2027-2032) & (USD Million)
Table 52. World Paclitaxel Drug-Eluting Balloon Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Paclitaxel Drug-Eluting Balloon Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Paclitaxel Drug-Eluting Balloon Production Value by Use Scenario, (USD Million), 2021 & 2025 & 2032
Table 55. World Paclitaxel Drug-Eluting Balloon Production by Use Scenario (2021-2026) & (K Units)
Table 56. World Paclitaxel Drug-Eluting Balloon Production by Use Scenario (2027-2032) & (K Units)
Table 57. World Paclitaxel Drug-Eluting Balloon Production Value by Use Scenario (2021-2026) & (USD Million)
Table 58. World Paclitaxel Drug-Eluting Balloon Production Value by Use Scenario (2027-2032) & (USD Million)
Table 59. World Paclitaxel Drug-Eluting Balloon Average Price by Use Scenario (2021-2026) & (US$/Unit)
Table 60. World Paclitaxel Drug-Eluting Balloon Average Price by Use Scenario (2027-2032) & (US$/Unit)
Table 61. World Paclitaxel Drug-Eluting Balloon Production Value by Balloon Platform Mechanics, (USD Million), 2021 & 2025 & 2032
Table 62. World Paclitaxel Drug-Eluting Balloon Production by Balloon Platform Mechanics (2021-2026) & (K Units)
Table 63. World Paclitaxel Drug-Eluting Balloon Production by Balloon Platform Mechanics (2027-2032) & (K Units)
Table 64. World Paclitaxel Drug-Eluting Balloon Production Value by Balloon Platform Mechanics (2021-2026) & (USD Million)
Table 65. World Paclitaxel Drug-Eluting Balloon Production Value by Balloon Platform Mechanics (2027-2032) & (USD Million)
Table 66. World Paclitaxel Drug-Eluting Balloon Average Price by Balloon Platform Mechanics (2021-2026) & (US$/Unit)
Table 67. World Paclitaxel Drug-Eluting Balloon Average Price by Balloon Platform Mechanics (2027-2032) & (US$/Unit)
Table 68. World Paclitaxel Drug-Eluting Balloon Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Paclitaxel Drug-Eluting Balloon Production by Application (2021-2026) & (K Units)
Table 70. World Paclitaxel Drug-Eluting Balloon Production by Application (2027-2032) & (K Units)
Table 71. World Paclitaxel Drug-Eluting Balloon Production Value by Application (2021-2026) & (USD Million)
Table 72. World Paclitaxel Drug-Eluting Balloon Production Value by Application (2027-2032) & (USD Million)
Table 73. World Paclitaxel Drug-Eluting Balloon Average Price by Application (2021-2026) & (US$/Unit)
Table 74. World Paclitaxel Drug-Eluting Balloon Average Price by Application (2027-2032) & (US$/Unit)
Table 75. B. Braun Basic Information, Manufacturing Base and Competitors
Table 76. B. Braun Major Business
Table 77. B. Braun Paclitaxel Drug-Eluting Balloon Product and Services
Table 78. B. Braun Paclitaxel Drug-Eluting Balloon Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. B. Braun Recent Developments/Updates
Table 80. B. Braun Competitive Strengths & Weaknesses
Table 81. Medtronic Basic Information, Manufacturing Base and Competitors
Table 82. Medtronic Major Business
Table 83. Medtronic Paclitaxel Drug-Eluting Balloon Product and Services
Table 84. Medtronic Paclitaxel Drug-Eluting Balloon Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Medtronic Recent Developments/Updates
Table 86. Medtronic Competitive Strengths & Weaknesses
Table 87. Boston Scientific Basic Information, Manufacturing Base and Competitors
Table 88. Boston Scientific Major Business
Table 89. Boston Scientific Paclitaxel Drug-Eluting Balloon Product and Services
Table 90. Boston Scientific Paclitaxel Drug-Eluting Balloon Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Boston Scientific Recent Developments/Updates
Table 92. Boston Scientific Competitive Strengths & Weaknesses
Table 93. BD Basic Information, Manufacturing Base and Competitors
Table 94. BD Major Business
Table 95. BD Paclitaxel Drug-Eluting Balloon Product and Services
Table 96. BD Paclitaxel Drug-Eluting Balloon Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. BD Recent Developments/Updates
Table 98. BD Competitive Strengths & Weaknesses
Table 99. Yinyi Biotechnology Basic Information, Manufacturing Base and Competitors
Table 100. Yinyi Biotechnology Major Business
Table 101. Yinyi Biotechnology Paclitaxel Drug-Eluting Balloon Product and Services
Table 102. Yinyi Biotechnology Paclitaxel Drug-Eluting Balloon Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Yinyi Biotechnology Recent Developments/Updates
Table 104. Yinyi Biotechnology Competitive Strengths & Weaknesses
Table 105. Acotec Basic Information, Manufacturing Base and Competitors
Table 106. Acotec Major Business
Table 107. Acotec Paclitaxel Drug-Eluting Balloon Product and Services
Table 108. Acotec Paclitaxel Drug-Eluting Balloon Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Acotec Recent Developments/Updates
Table 110. Acotec Competitive Strengths & Weaknesses
Table 111. Philips Basic Information, Manufacturing Base and Competitors
Table 112. Philips Major Business
Table 113. Philips Paclitaxel Drug-Eluting Balloon Product and Services
Table 114. Philips Paclitaxel Drug-Eluting Balloon Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Philips Recent Developments/Updates
Table 116. Philips Competitive Strengths & Weaknesses
Table 117. Lepu Medical Basic Information, Manufacturing Base and Competitors
Table 118. Lepu Medical Major Business
Table 119. Lepu Medical Paclitaxel Drug-Eluting Balloon Product and Services
Table 120. Lepu Medical Paclitaxel Drug-Eluting Balloon Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. Lepu Medical Recent Developments/Updates
Table 122. Lepu Medical Competitive Strengths & Weaknesses
Table 123. Eurocor Basic Information, Manufacturing Base and Competitors
Table 124. Eurocor Major Business
Table 125. Eurocor Paclitaxel Drug-Eluting Balloon Product and Services
Table 126. Eurocor Paclitaxel Drug-Eluting Balloon Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Eurocor Recent Developments/Updates
Table 128. Eurocor Competitive Strengths & Weaknesses
Table 129. MicroPort Medical Basic Information, Manufacturing Base and Competitors
Table 130. MicroPort Medical Major Business
Table 131. MicroPort Medical Paclitaxel Drug-Eluting Balloon Product and Services
Table 132. MicroPort Medical Paclitaxel Drug-Eluting Balloon Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. MicroPort Medical Recent Developments/Updates
Table 134. MicroPort Medical Competitive Strengths & Weaknesses
Table 135. Teleflex Basic Information, Manufacturing Base and Competitors
Table 136. Teleflex Major Business
Table 137. Teleflex Paclitaxel Drug-Eluting Balloon Product and Services
Table 138. Teleflex Paclitaxel Drug-Eluting Balloon Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. Teleflex Recent Developments/Updates
Table 140. Teleflex Competitive Strengths & Weaknesses
Table 141. Global Key Players of Paclitaxel Drug-Eluting Balloon Upstream (Raw Materials)
Table 142. Global Paclitaxel Drug-Eluting Balloon Typical Customers
Table 143. Paclitaxel Drug-Eluting Balloon Typical Distributors
Table 1. World Paclitaxel Drug-Eluting Balloon Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Paclitaxel Drug-Eluting Balloon Production Value by Region (2021-2026) & (USD Million)
Table 3. World Paclitaxel Drug-Eluting Balloon Production Value by Region (2027-2032) & (USD Million)
Table 4. World Paclitaxel Drug-Eluting Balloon Production Value Market Share by Region (2021-2026)
Table 5. World Paclitaxel Drug-Eluting Balloon Production Value Market Share by Region (2027-2032)
Table 6. World Paclitaxel Drug-Eluting Balloon Production by Region (2021-2026) & (K Units)
Table 7. World Paclitaxel Drug-Eluting Balloon Production by Region (2027-2032) & (K Units)
Table 8. World Paclitaxel Drug-Eluting Balloon Production Market Share by Region (2021-2026)
Table 9. World Paclitaxel Drug-Eluting Balloon Production Market Share by Region (2027-2032)
Table 10. World Paclitaxel Drug-Eluting Balloon Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Paclitaxel Drug-Eluting Balloon Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Paclitaxel Drug-Eluting Balloon Major Market Trends
Table 13. World Paclitaxel Drug-Eluting Balloon Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Units)
Table 14. World Paclitaxel Drug-Eluting Balloon Consumption by Region (2021-2026) & (K Units)
Table 15. World Paclitaxel Drug-Eluting Balloon Consumption Forecast by Region (2027-2032) & (K Units)
Table 16. World Paclitaxel Drug-Eluting Balloon Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Paclitaxel Drug-Eluting Balloon Producers in 2025
Table 18. World Paclitaxel Drug-Eluting Balloon Production by Manufacturer (2021-2026) & (K Units)
Table 19. Production Market Share of Key Paclitaxel Drug-Eluting Balloon Producers in 2025
Table 20. World Paclitaxel Drug-Eluting Balloon Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Paclitaxel Drug-Eluting Balloon Company Evaluation Quadrant
Table 22. World Paclitaxel Drug-Eluting Balloon Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Paclitaxel Drug-Eluting Balloon Production Site of Key Manufacturer
Table 24. Paclitaxel Drug-Eluting Balloon Market: Company Product Type Footprint
Table 25. Paclitaxel Drug-Eluting Balloon Market: Company Product Application Footprint
Table 26. Paclitaxel Drug-Eluting Balloon Competitive Factors
Table 27. Paclitaxel Drug-Eluting Balloon New Entrant and Capacity Expansion Plans
Table 28. Paclitaxel Drug-Eluting Balloon Mergers & Acquisitions Activity
Table 29. United States VS China Paclitaxel Drug-Eluting Balloon Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Paclitaxel Drug-Eluting Balloon Production Comparison, (2021 & 2025 & 2032) & (K Units)
Table 31. United States VS China Paclitaxel Drug-Eluting Balloon Consumption Comparison, (2021 & 2025 & 2032) & (K Units)
Table 32. United States Based Paclitaxel Drug-Eluting Balloon Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Paclitaxel Drug-Eluting Balloon Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Paclitaxel Drug-Eluting Balloon Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Paclitaxel Drug-Eluting Balloon Production (2021-2026) & (K Units)
Table 36. United States Based Manufacturers Paclitaxel Drug-Eluting Balloon Production Market Share (2021-2026)
Table 37. China Based Paclitaxel Drug-Eluting Balloon Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Paclitaxel Drug-Eluting Balloon Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Paclitaxel Drug-Eluting Balloon Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Paclitaxel Drug-Eluting Balloon Production, (2021-2026) & (K Units)
Table 41. China Based Manufacturers Paclitaxel Drug-Eluting Balloon Production Market Share (2021-2026)
Table 42. Rest of World Based Paclitaxel Drug-Eluting Balloon Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Paclitaxel Drug-Eluting Balloon Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Paclitaxel Drug-Eluting Balloon Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Paclitaxel Drug-Eluting Balloon Production, (2021-2026) & (K Units)
Table 46. Rest of World Based Manufacturers Paclitaxel Drug-Eluting Balloon Production Market Share (2021-2026)
Table 47. World Paclitaxel Drug-Eluting Balloon Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Paclitaxel Drug-Eluting Balloon Production by Type (2021-2026) & (K Units)
Table 49. World Paclitaxel Drug-Eluting Balloon Production by Type (2027-2032) & (K Units)
Table 50. World Paclitaxel Drug-Eluting Balloon Production Value by Type (2021-2026) & (USD Million)
Table 51. World Paclitaxel Drug-Eluting Balloon Production Value by Type (2027-2032) & (USD Million)
Table 52. World Paclitaxel Drug-Eluting Balloon Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Paclitaxel Drug-Eluting Balloon Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Paclitaxel Drug-Eluting Balloon Production Value by Use Scenario, (USD Million), 2021 & 2025 & 2032
Table 55. World Paclitaxel Drug-Eluting Balloon Production by Use Scenario (2021-2026) & (K Units)
Table 56. World Paclitaxel Drug-Eluting Balloon Production by Use Scenario (2027-2032) & (K Units)
Table 57. World Paclitaxel Drug-Eluting Balloon Production Value by Use Scenario (2021-2026) & (USD Million)
Table 58. World Paclitaxel Drug-Eluting Balloon Production Value by Use Scenario (2027-2032) & (USD Million)
Table 59. World Paclitaxel Drug-Eluting Balloon Average Price by Use Scenario (2021-2026) & (US$/Unit)
Table 60. World Paclitaxel Drug-Eluting Balloon Average Price by Use Scenario (2027-2032) & (US$/Unit)
Table 61. World Paclitaxel Drug-Eluting Balloon Production Value by Balloon Platform Mechanics, (USD Million), 2021 & 2025 & 2032
Table 62. World Paclitaxel Drug-Eluting Balloon Production by Balloon Platform Mechanics (2021-2026) & (K Units)
Table 63. World Paclitaxel Drug-Eluting Balloon Production by Balloon Platform Mechanics (2027-2032) & (K Units)
Table 64. World Paclitaxel Drug-Eluting Balloon Production Value by Balloon Platform Mechanics (2021-2026) & (USD Million)
Table 65. World Paclitaxel Drug-Eluting Balloon Production Value by Balloon Platform Mechanics (2027-2032) & (USD Million)
Table 66. World Paclitaxel Drug-Eluting Balloon Average Price by Balloon Platform Mechanics (2021-2026) & (US$/Unit)
Table 67. World Paclitaxel Drug-Eluting Balloon Average Price by Balloon Platform Mechanics (2027-2032) & (US$/Unit)
Table 68. World Paclitaxel Drug-Eluting Balloon Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Paclitaxel Drug-Eluting Balloon Production by Application (2021-2026) & (K Units)
Table 70. World Paclitaxel Drug-Eluting Balloon Production by Application (2027-2032) & (K Units)
Table 71. World Paclitaxel Drug-Eluting Balloon Production Value by Application (2021-2026) & (USD Million)
Table 72. World Paclitaxel Drug-Eluting Balloon Production Value by Application (2027-2032) & (USD Million)
Table 73. World Paclitaxel Drug-Eluting Balloon Average Price by Application (2021-2026) & (US$/Unit)
Table 74. World Paclitaxel Drug-Eluting Balloon Average Price by Application (2027-2032) & (US$/Unit)
Table 75. B. Braun Basic Information, Manufacturing Base and Competitors
Table 76. B. Braun Major Business
Table 77. B. Braun Paclitaxel Drug-Eluting Balloon Product and Services
Table 78. B. Braun Paclitaxel Drug-Eluting Balloon Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. B. Braun Recent Developments/Updates
Table 80. B. Braun Competitive Strengths & Weaknesses
Table 81. Medtronic Basic Information, Manufacturing Base and Competitors
Table 82. Medtronic Major Business
Table 83. Medtronic Paclitaxel Drug-Eluting Balloon Product and Services
Table 84. Medtronic Paclitaxel Drug-Eluting Balloon Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Medtronic Recent Developments/Updates
Table 86. Medtronic Competitive Strengths & Weaknesses
Table 87. Boston Scientific Basic Information, Manufacturing Base and Competitors
Table 88. Boston Scientific Major Business
Table 89. Boston Scientific Paclitaxel Drug-Eluting Balloon Product and Services
Table 90. Boston Scientific Paclitaxel Drug-Eluting Balloon Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Boston Scientific Recent Developments/Updates
Table 92. Boston Scientific Competitive Strengths & Weaknesses
Table 93. BD Basic Information, Manufacturing Base and Competitors
Table 94. BD Major Business
Table 95. BD Paclitaxel Drug-Eluting Balloon Product and Services
Table 96. BD Paclitaxel Drug-Eluting Balloon Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. BD Recent Developments/Updates
Table 98. BD Competitive Strengths & Weaknesses
Table 99. Yinyi Biotechnology Basic Information, Manufacturing Base and Competitors
Table 100. Yinyi Biotechnology Major Business
Table 101. Yinyi Biotechnology Paclitaxel Drug-Eluting Balloon Product and Services
Table 102. Yinyi Biotechnology Paclitaxel Drug-Eluting Balloon Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Yinyi Biotechnology Recent Developments/Updates
Table 104. Yinyi Biotechnology Competitive Strengths & Weaknesses
Table 105. Acotec Basic Information, Manufacturing Base and Competitors
Table 106. Acotec Major Business
Table 107. Acotec Paclitaxel Drug-Eluting Balloon Product and Services
Table 108. Acotec Paclitaxel Drug-Eluting Balloon Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Acotec Recent Developments/Updates
Table 110. Acotec Competitive Strengths & Weaknesses
Table 111. Philips Basic Information, Manufacturing Base and Competitors
Table 112. Philips Major Business
Table 113. Philips Paclitaxel Drug-Eluting Balloon Product and Services
Table 114. Philips Paclitaxel Drug-Eluting Balloon Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Philips Recent Developments/Updates
Table 116. Philips Competitive Strengths & Weaknesses
Table 117. Lepu Medical Basic Information, Manufacturing Base and Competitors
Table 118. Lepu Medical Major Business
Table 119. Lepu Medical Paclitaxel Drug-Eluting Balloon Product and Services
Table 120. Lepu Medical Paclitaxel Drug-Eluting Balloon Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. Lepu Medical Recent Developments/Updates
Table 122. Lepu Medical Competitive Strengths & Weaknesses
Table 123. Eurocor Basic Information, Manufacturing Base and Competitors
Table 124. Eurocor Major Business
Table 125. Eurocor Paclitaxel Drug-Eluting Balloon Product and Services
Table 126. Eurocor Paclitaxel Drug-Eluting Balloon Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Eurocor Recent Developments/Updates
Table 128. Eurocor Competitive Strengths & Weaknesses
Table 129. MicroPort Medical Basic Information, Manufacturing Base and Competitors
Table 130. MicroPort Medical Major Business
Table 131. MicroPort Medical Paclitaxel Drug-Eluting Balloon Product and Services
Table 132. MicroPort Medical Paclitaxel Drug-Eluting Balloon Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. MicroPort Medical Recent Developments/Updates
Table 134. MicroPort Medical Competitive Strengths & Weaknesses
Table 135. Teleflex Basic Information, Manufacturing Base and Competitors
Table 136. Teleflex Major Business
Table 137. Teleflex Paclitaxel Drug-Eluting Balloon Product and Services
Table 138. Teleflex Paclitaxel Drug-Eluting Balloon Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. Teleflex Recent Developments/Updates
Table 140. Teleflex Competitive Strengths & Weaknesses
Table 141. Global Key Players of Paclitaxel Drug-Eluting Balloon Upstream (Raw Materials)
Table 142. Global Paclitaxel Drug-Eluting Balloon Typical Customers
Table 143. Paclitaxel Drug-Eluting Balloon Typical Distributors
LIST OF FIGURES
Figure 1. Paclitaxel Drug-Eluting Balloon Picture
Figure 2. World Paclitaxel Drug-Eluting Balloon Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Paclitaxel Drug-Eluting Balloon Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Paclitaxel Drug-Eluting Balloon Production (2021-2032) & (K Units)
Figure 5. World Paclitaxel Drug-Eluting Balloon Average Price (2021-2032) & (US$/Unit)
Figure 6. World Paclitaxel Drug-Eluting Balloon Production Value Market Share by Region (2021-2032)
Figure 7. World Paclitaxel Drug-Eluting Balloon Production Market Share by Region (2021-2032)
Figure 8. North America Paclitaxel Drug-Eluting Balloon Production (2021-2032) & (K Units)
Figure 9. Europe Paclitaxel Drug-Eluting Balloon Production (2021-2032) & (K Units)
Figure 10. China Paclitaxel Drug-Eluting Balloon Production (2021-2032) & (K Units)
Figure 11. Japan Paclitaxel Drug-Eluting Balloon Production (2021-2032) & (K Units)
Figure 12. Paclitaxel Drug-Eluting Balloon Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Paclitaxel Drug-Eluting Balloon Consumption (2021-2032) & (K Units)
Figure 15. World Paclitaxel Drug-Eluting Balloon Consumption Market Share by Region (2021-2032)
Figure 16. United States Paclitaxel Drug-Eluting Balloon Consumption (2021-2032) & (K Units)
Figure 17. China Paclitaxel Drug-Eluting Balloon Consumption (2021-2032) & (K Units)
Figure 18. Europe Paclitaxel Drug-Eluting Balloon Consumption (2021-2032) & (K Units)
Figure 19. Japan Paclitaxel Drug-Eluting Balloon Consumption (2021-2032) & (K Units)
Figure 20. South Korea Paclitaxel Drug-Eluting Balloon Consumption (2021-2032) & (K Units)
Figure 21. ASEAN Paclitaxel Drug-Eluting Balloon Consumption (2021-2032) & (K Units)
Figure 22. India Paclitaxel Drug-Eluting Balloon Consumption (2021-2032) & (K Units)
Figure 23. Producer Shipments of Paclitaxel Drug-Eluting Balloon by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Paclitaxel Drug-Eluting Balloon Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Paclitaxel Drug-Eluting Balloon Markets in 2025
Figure 26. United States VS China: Paclitaxel Drug-Eluting Balloon Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Paclitaxel Drug-Eluting Balloon Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Paclitaxel Drug-Eluting Balloon Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Paclitaxel Drug-Eluting Balloon Production Market Share 2025
Figure 30. China Based Manufacturers Paclitaxel Drug-Eluting Balloon Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Paclitaxel Drug-Eluting Balloon Production Market Share 2025
Figure 32. World Paclitaxel Drug-Eluting Balloon Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Paclitaxel Drug-Eluting Balloon Production Value Market Share by Type in 2025
Figure 34. Peripheral DEB
Figure 35. Coronary DEB
Figure 36. World Paclitaxel Drug-Eluting Balloon Production Market Share by Type (2021-2032)
Figure 37. World Paclitaxel Drug-Eluting Balloon Production Value Market Share by Type (2021-2032)
Figure 38. World Paclitaxel Drug-Eluting Balloon Average Price by Type (2021-2032) & (US$/Unit)
Figure 39. World Paclitaxel Drug-Eluting Balloon Production Value by Use Scenario, (USD Million), 2021 & 2025 & 2032
Figure 40. World Paclitaxel Drug-Eluting Balloon Production Value Market Share by Use Scenario in 2025
Figure 41. In-Stent Restenosi
Figure 42. De Novo
Figure 43. Small Vessel
Figure 44. World Paclitaxel Drug-Eluting Balloon Production Market Share by Use Scenario (2021-2032)
Figure 45. World Paclitaxel Drug-Eluting Balloon Production Value Market Share by Use Scenario (2021-2032)
Figure 46. World Paclitaxel Drug-Eluting Balloon Average Price by Use Scenario (2021-2032) & (US$/Unit)
Figure 47. World Paclitaxel Drug-Eluting Balloon Production Value by Balloon Platform Mechanics, (USD Million), 2021 & 2025 & 2032
Figure 48. World Paclitaxel Drug-Eluting Balloon Production Value Market Share by Balloon Platform Mechanics in 2025
Figure 49. Semi-/Compliant
Figure 50. Non-compliant
Figure 51. Other
Figure 52. World Paclitaxel Drug-Eluting Balloon Production Market Share by Balloon Platform Mechanics (2021-2032)
Figure 53. World Paclitaxel Drug-Eluting Balloon Production Value Market Share by Balloon Platform Mechanics (2021-2032)
Figure 54. World Paclitaxel Drug-Eluting Balloon Average Price by Balloon Platform Mechanics (2021-2032) & (US$/Unit)
Figure 55. World Paclitaxel Drug-Eluting Balloon Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 56. World Paclitaxel Drug-Eluting Balloon Production Value Market Share by Application in 2025
Figure 57. Cardiac Catheterization Lab
Figure 58. Hospital
Figure 59. Other
Figure 60. World Paclitaxel Drug-Eluting Balloon Production Market Share by Application (2021-2032)
Figure 61. World Paclitaxel Drug-Eluting Balloon Production Value Market Share by Application (2021-2032)
Figure 62. World Paclitaxel Drug-Eluting Balloon Average Price by Application (2021-2032) & (US$/Unit)
Figure 63. Paclitaxel Drug-Eluting Balloon Industry Chain
Figure 64. Paclitaxel Drug-Eluting Balloon Procurement Model
Figure 65. Paclitaxel Drug-Eluting Balloon Sales Model
Figure 66. Paclitaxel Drug-Eluting Balloon Sales Channels, Direct Sales, and Distribution
Figure 67. Methodology
Figure 68. Research Process and Data Source
Figure 1. Paclitaxel Drug-Eluting Balloon Picture
Figure 2. World Paclitaxel Drug-Eluting Balloon Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Paclitaxel Drug-Eluting Balloon Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Paclitaxel Drug-Eluting Balloon Production (2021-2032) & (K Units)
Figure 5. World Paclitaxel Drug-Eluting Balloon Average Price (2021-2032) & (US$/Unit)
Figure 6. World Paclitaxel Drug-Eluting Balloon Production Value Market Share by Region (2021-2032)
Figure 7. World Paclitaxel Drug-Eluting Balloon Production Market Share by Region (2021-2032)
Figure 8. North America Paclitaxel Drug-Eluting Balloon Production (2021-2032) & (K Units)
Figure 9. Europe Paclitaxel Drug-Eluting Balloon Production (2021-2032) & (K Units)
Figure 10. China Paclitaxel Drug-Eluting Balloon Production (2021-2032) & (K Units)
Figure 11. Japan Paclitaxel Drug-Eluting Balloon Production (2021-2032) & (K Units)
Figure 12. Paclitaxel Drug-Eluting Balloon Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Paclitaxel Drug-Eluting Balloon Consumption (2021-2032) & (K Units)
Figure 15. World Paclitaxel Drug-Eluting Balloon Consumption Market Share by Region (2021-2032)
Figure 16. United States Paclitaxel Drug-Eluting Balloon Consumption (2021-2032) & (K Units)
Figure 17. China Paclitaxel Drug-Eluting Balloon Consumption (2021-2032) & (K Units)
Figure 18. Europe Paclitaxel Drug-Eluting Balloon Consumption (2021-2032) & (K Units)
Figure 19. Japan Paclitaxel Drug-Eluting Balloon Consumption (2021-2032) & (K Units)
Figure 20. South Korea Paclitaxel Drug-Eluting Balloon Consumption (2021-2032) & (K Units)
Figure 21. ASEAN Paclitaxel Drug-Eluting Balloon Consumption (2021-2032) & (K Units)
Figure 22. India Paclitaxel Drug-Eluting Balloon Consumption (2021-2032) & (K Units)
Figure 23. Producer Shipments of Paclitaxel Drug-Eluting Balloon by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Paclitaxel Drug-Eluting Balloon Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Paclitaxel Drug-Eluting Balloon Markets in 2025
Figure 26. United States VS China: Paclitaxel Drug-Eluting Balloon Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Paclitaxel Drug-Eluting Balloon Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Paclitaxel Drug-Eluting Balloon Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Paclitaxel Drug-Eluting Balloon Production Market Share 2025
Figure 30. China Based Manufacturers Paclitaxel Drug-Eluting Balloon Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Paclitaxel Drug-Eluting Balloon Production Market Share 2025
Figure 32. World Paclitaxel Drug-Eluting Balloon Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Paclitaxel Drug-Eluting Balloon Production Value Market Share by Type in 2025
Figure 34. Peripheral DEB
Figure 35. Coronary DEB
Figure 36. World Paclitaxel Drug-Eluting Balloon Production Market Share by Type (2021-2032)
Figure 37. World Paclitaxel Drug-Eluting Balloon Production Value Market Share by Type (2021-2032)
Figure 38. World Paclitaxel Drug-Eluting Balloon Average Price by Type (2021-2032) & (US$/Unit)
Figure 39. World Paclitaxel Drug-Eluting Balloon Production Value by Use Scenario, (USD Million), 2021 & 2025 & 2032
Figure 40. World Paclitaxel Drug-Eluting Balloon Production Value Market Share by Use Scenario in 2025
Figure 41. In-Stent Restenosi
Figure 42. De Novo
Figure 43. Small Vessel
Figure 44. World Paclitaxel Drug-Eluting Balloon Production Market Share by Use Scenario (2021-2032)
Figure 45. World Paclitaxel Drug-Eluting Balloon Production Value Market Share by Use Scenario (2021-2032)
Figure 46. World Paclitaxel Drug-Eluting Balloon Average Price by Use Scenario (2021-2032) & (US$/Unit)
Figure 47. World Paclitaxel Drug-Eluting Balloon Production Value by Balloon Platform Mechanics, (USD Million), 2021 & 2025 & 2032
Figure 48. World Paclitaxel Drug-Eluting Balloon Production Value Market Share by Balloon Platform Mechanics in 2025
Figure 49. Semi-/Compliant
Figure 50. Non-compliant
Figure 51. Other
Figure 52. World Paclitaxel Drug-Eluting Balloon Production Market Share by Balloon Platform Mechanics (2021-2032)
Figure 53. World Paclitaxel Drug-Eluting Balloon Production Value Market Share by Balloon Platform Mechanics (2021-2032)
Figure 54. World Paclitaxel Drug-Eluting Balloon Average Price by Balloon Platform Mechanics (2021-2032) & (US$/Unit)
Figure 55. World Paclitaxel Drug-Eluting Balloon Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 56. World Paclitaxel Drug-Eluting Balloon Production Value Market Share by Application in 2025
Figure 57. Cardiac Catheterization Lab
Figure 58. Hospital
Figure 59. Other
Figure 60. World Paclitaxel Drug-Eluting Balloon Production Market Share by Application (2021-2032)
Figure 61. World Paclitaxel Drug-Eluting Balloon Production Value Market Share by Application (2021-2032)
Figure 62. World Paclitaxel Drug-Eluting Balloon Average Price by Application (2021-2032) & (US$/Unit)
Figure 63. Paclitaxel Drug-Eluting Balloon Industry Chain
Figure 64. Paclitaxel Drug-Eluting Balloon Procurement Model
Figure 65. Paclitaxel Drug-Eluting Balloon Sales Model
Figure 66. Paclitaxel Drug-Eluting Balloon Sales Channels, Direct Sales, and Distribution
Figure 67. Methodology
Figure 68. Research Process and Data Source
